Compare STTK & MAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STTK | MAPS |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.0M | 106.3M |
| IPO Year | 2020 | N/A |
| Metric | STTK | MAPS |
|---|---|---|
| Price | $2.60 | $0.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $4.00 | $2.61 |
| AVG Volume (30 Days) | 171.3K | ★ 851.7K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | $1,000,000.00 | ★ $179,305,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.43 |
| P/E Ratio | ★ N/A | $12.44 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.69 | $0.72 |
| 52 Week High | $2.71 | $1.65 |
| Indicator | STTK | MAPS |
|---|---|---|
| Relative Strength Index (RSI) | 71.07 | 44.17 |
| Support Level | $1.93 | $0.84 |
| Resistance Level | $2.18 | $0.90 |
| Average True Range (ATR) | 0.18 | 0.05 |
| MACD | 0.07 | 0.01 |
| Stochastic Oscillator | 97.78 | 61.83 |
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises the B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on marketplace ads.